These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Corrigendum to "Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effects" [Bioorg. Med. Chem. Lett. 26 (2016) 5724-5728]. Lombardo M; Bender K; London C; Plotkin MA; Kirkland M; Mane J; Pachanski M; Geissler W; Cummings J; Habulihaz B; Akiyama TE; Di Salvo J; Madeira M; Pols J; Powles MA; Finley MF; Johnson E; Roussel T; Uebele VN; Crespo A; Leung D; Alleyne C; Trusca D; Lei Y; Howard AD; Ujjainwalla F; Tata JR; Sinz CJ Bioorg Med Chem Lett; 2017 Mar; 27(5):1333. PubMed ID: 28169160 [No Abstract] [Full Text] [Related]
8. Corrigendum to "Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors" [Bioorg. Med. Chem. Lett. 24 (2014) 5093-5097]. Kang ST; Kim EY; Achary R; Jung H; Park CH; Yun CS; Hwang JY; Choi SU; Chae C; Lee CO; Kim HR; Ha JD; Ryu D; Cho SY Bioorg Med Chem Lett; 2017 Jul; 27(14):3205. PubMed ID: 28551102 [No Abstract] [Full Text] [Related]
9. Corrigendum to "Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury" [Bioorg. Med. Chem. Lett. 29(8) (2019) 995-1000]. Goncalves MB; Clarke E; Jarvis CI; Kalindjian SB; Pitcher T; Grist J; Hobbs C; Carlstedt T; Jack J; Brown JT; Mills M; Mumford P; Borthwick AD; Corcoran JPT Bioorg Med Chem Lett; 2019 Aug; 29(16):2440-2441. PubMed ID: 31208764 [No Abstract] [Full Text] [Related]
10. Corrigendum to 'Easy and rapid preparation of benzoylhydrazides and their diazene derivatives as inhibitors of 15-lipoxygenase' [Bioorg. Med. Chem. Lett. 27 (2017) 1649-1653]. Tirapegui C; Acevedo-Fuentes W; Dahech P; Torrent C; Barrias P; Rojas-Poblete M; Mascayano C Bioorg Med Chem Lett; 2017 Sep; 27(17):4218. PubMed ID: 28780158 [No Abstract] [Full Text] [Related]
11. Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431]. Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM Bioorg Med Chem Lett; 2016 Sep; 26(18):4558. PubMed ID: 27542309 [No Abstract] [Full Text] [Related]
12. Corrigendum to "Chemical space screening around Phe Willemse T; Eiselt E; Hollanders K; Schepens W; van Vlijmen HWT; Chung NN; Blais V; Holleran B; Longpré JM; Schiller PW; Maes BUW; Sarret P; Gendron L; Ballet S Bioorg Med Chem Lett; 2018 Nov; 28(20):3418. PubMed ID: 30195888 [No Abstract] [Full Text] [Related]
13. Corrigendum to "Design, synthesis, biological evaluation, and molecular docking of chalcone derivatives as anti-inflammatory agents" [Bioorg. Med. Chem. Lett. 27 (3) (2017) 602-606]. Li J; Li D; Xu Y; Guo Z; Liu X; Yang H; Wu L; Wang L Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3822. PubMed ID: 30385163 [No Abstract] [Full Text] [Related]
14. Corrigendum to "1-Thiazol-2-yl-N-3-methyl-1H-pyrozole-5-carboxylic acid derivatives as antitumor agents" [Bioorg. Med. Chem. Lett. 27 (2017) 4471-4477]. Cooper AB; Ciblat S; Shipps G; Levine J; Kostura M; Oza V; Constantineau-Forget L; Dery M; Grand-Maitre C; Bruneau-Latour N; Bellavance E; Patane M; Siddiqui A; Luther M Bioorg Med Chem Lett; 2018 Mar; 28(5):985. PubMed ID: 29433931 [No Abstract] [Full Text] [Related]
15. Corrigendum to "Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1" [Bioorg. Med. Chem. Lett. 26 (2016) 4919-4924]. Monteillier A; Loucif A; Omoto K; Stevens EB; Lainez S; Saintot PP; Cao L; Pryde DC Bioorg Med Chem Lett; 2017 May; 27(9):2082. PubMed ID: 28320618 [No Abstract] [Full Text] [Related]
16. Corrigendum to "A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives" [Bioorg. Med. Chem. Lett. 28 (14) (2018) 2481-2484]. Derabli C; Boualia I; Abdelwahab AB; Boulcina R; Bensouici C; Kirsch G; Debache A Bioorg Med Chem Lett; 2018 Oct; 28(18):3129. PubMed ID: 30119958 [No Abstract] [Full Text] [Related]
17. Corrigendum to "Syntheses and antimicrobial activities of ogipeptin derivatives" [Bioorg. Med. Chem. Lett. 42 (2021) 128093]. Takiguchi S; Homma H; Fujisawa T; Hirota-Takahata Y; Ono Y; Kizuka M; Ishii Y; Yoshimura S; Nishi T Bioorg Med Chem Lett; 2021 Sep; 47():128228. PubMed ID: 34192636 [No Abstract] [Full Text] [Related]
18. Corrigendum to "Strategies for the development of highly selective cytochrome P450 inhibitors: Several CYP targets in current research" [Bioorg. Med. Chem. Lett. 29 (2019) 2016-2024]. Zhao L; Sun N; Tian L; Zhao S; Sun B; Sun Y; Zhao D Bioorg Med Chem Lett; 2021 Aug; 45():128140. PubMed ID: 34052643 [No Abstract] [Full Text] [Related]
19. Corrigendum to "Anti-cancer potential of (1,2-dihydronaphtho[2,1-b]furan-2-yl)methanone derivatives" [Bioorg. Med. Chem. Lett. 30 (2020) 127476]. Islam K; Pal K; Debnath U; Basha RS; Khan AT; Jana K; Misra AK Bioorg Med Chem Lett; 2021 Feb; 34():127764. PubMed ID: 33401154 [No Abstract] [Full Text] [Related]
20. Corrigendum to "Identification of 2-substituted pyrrolo[1,2-b]pyridazine derivatives as new PARP-1 inhibitors" [Bioorg. Med. Chem. Lett. 31 (2021) 127710]. Xiang HY; Chen JY; Huan XJ; Chen Y; Gao ZB; Ding J; Miao ZH; Yang CH Bioorg Med Chem Lett; 2022 Jan; 56():128501. PubMed ID: 34911648 [No Abstract] [Full Text] [Related] [Next] [New Search]